Related Experiment Video

Updated: Mar 19, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

12.7K

Review of vancomycin-induced renal toxicity: an update

Oluwatoyin Bamgbola1

  • 1State University of New York Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203-2098, USA.

Therapeutic Advances in Endocrinology and Metabolism
|June 14, 2016
PubMed

Insights

Higher vancomycin doses, used to combat resistant Staphylococcus aureus, are linked to increased acute kidney injury (AKI). Monitoring drug levels and maintaining kidney perfusion are key prevention strategies.

Area of Science:

  • Nephrology
  • Pharmacology
  • Infectious Diseases

Background:

  • Rising incidence of antibiotic-resistant Staphylococcus aureus necessitates higher vancomycin dosages.
  • Increased vancomycin use is associated with a higher reported incidence of acute kidney injury (AKI).

Purpose of the Study:

  • To explore the relationship between vancomycin dosing and the occurrence of AKI.
  • To identify risk factors and prevention strategies for vancomycin-induced nephrotoxicity.

Main Methods:

  • Observational analysis of patient data correlating vancomycin dosage, duration, and plasma concentrations with AKI incidence.
  • Review of factors contributing to AKI, including concurrent nephrotoxic agent use and patient critical illness status.

Main Results:

  • Causality between vancomycin and AKI is suggested by dose- and concentration-dependent associations.
  • Concurrent nephrotoxic agents and critical illness increase the risk of vancomycin-induced AKI.
  • While often reversible, vancomycin-induced AKI can lead to end-stage kidney disease and increased mortality.

Conclusions:

  • Therapeutic drug monitoring and maintaining adequate renal perfusion are crucial for preventing vancomycin-associated AKI.
  • Future research may explore renoprotective strategies, such as antioxidative substances, in vancomycin delivery.
Keywords:
Acute Kidney InjuryCritical IllnessNephrotoxicityRisk factorsVancomycinVancomycin Resistance

More Related Videos

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

7.8K
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.9K

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
568
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
1.1K
Renal Drug Excretion: Overview01:15

Renal Drug Excretion: Overview

As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
924
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
1.0K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
455
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
331